Table 3.

Clinical features of patients with identified pathogenic variants

Gene and mode of inheritanceAge at diagnosis of ITP, yFamily history of thrombocytopeniaEthnicityPlatelet count nadir, ×109/LTreatment for ITPEffect on managementReference
ETV6 p.Arg369Trp
Dominant missense variant 
47 No White 34 Limited/no response to splenectomy, azathioprine, steroids
Complete response to romiplostim 
Patient had gone through many ineffective immunosuppressive agents before romiplostim was licensed. 22  
ANKRD26 c.-116C>G
Dominant 5′UTR variant 
30 No Asian 45 Not required Give platelets for procedures, monitor for malignancy 23  
GP1BB p.Leu16Pro
Dominant missense variant 
Yes (maternal thrombocytopenia in pregnancy) White 13 Short-lived response to steroids, partial response to eltrombopag and romiplostim Use of HLA-matched platelet transfusions 24  
TUBB1 p.Asn347Lys
Dominant missense variant 
62 Yes (daughter has thrombocytopenia) White 62 Not required Give platelets for procedures 7  
UNC13D p.Val210Tr[fs]Ter39
p.Leu409Pro
Recessive variants: 1 frameshift, 1 missense 
19 No White Complete response to steroids and Mycophenolate Mofetil Pathogenic variants only confirmed after patient developed symptoms of HLH aged 26 y (sequencing was re-examined). Diagnosis led to allogeneic stem cell transplant curative treatment. 25  
Gene and mode of inheritanceAge at diagnosis of ITP, yFamily history of thrombocytopeniaEthnicityPlatelet count nadir, ×109/LTreatment for ITPEffect on managementReference
ETV6 p.Arg369Trp
Dominant missense variant 
47 No White 34 Limited/no response to splenectomy, azathioprine, steroids
Complete response to romiplostim 
Patient had gone through many ineffective immunosuppressive agents before romiplostim was licensed. 22  
ANKRD26 c.-116C>G
Dominant 5′UTR variant 
30 No Asian 45 Not required Give platelets for procedures, monitor for malignancy 23  
GP1BB p.Leu16Pro
Dominant missense variant 
Yes (maternal thrombocytopenia in pregnancy) White 13 Short-lived response to steroids, partial response to eltrombopag and romiplostim Use of HLA-matched platelet transfusions 24  
TUBB1 p.Asn347Lys
Dominant missense variant 
62 Yes (daughter has thrombocytopenia) White 62 Not required Give platelets for procedures 7  
UNC13D p.Val210Tr[fs]Ter39
p.Leu409Pro
Recessive variants: 1 frameshift, 1 missense 
19 No White Complete response to steroids and Mycophenolate Mofetil Pathogenic variants only confirmed after patient developed symptoms of HLH aged 26 y (sequencing was re-examined). Diagnosis led to allogeneic stem cell transplant curative treatment. 25  

or Create an Account

Close Modal
Close Modal